Sitavig
Product Images NDC 71403-049

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Sitavig (NDC 71403-049). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Epi Health, Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Sitavig 01)

Chemical structure of the active ingredient in Sitavig, showing a nucleoside analog with a bicyclic purine base attached to a sugar moiety substituted with an amino and hydroxyl group.*

FDA Label Image

Figure A (Sitavig 02)

Illustration showing the application area for the Sitavig tablet, depicting a hand placing the tablet against the gum above the upper front teeth inside the mouth. The diagram highlights the specific location where the Sitavig tablet should be applied.*

FDA Label Image

Figure B (Sitavig 03)

Sitavig tablets by EPI Health, Inc shown in close-up images displaying the oblong, white tablet shape. The images focus on the tablet's side profile without visible imprint or markings.*

FDA Label Image

Figure C (Sitavig 04)

An instructional illustration showing a person placing a small circular tablet inside their mouth onto the upper gum above the teeth using their finger. The image focuses on the application process of a medication, likely depicting proper placement of the product for buccal absorption.*

FDA Label Image

Figure D (Sitavig 05)

An illustration showing a person placing a tablet onto their upper gum above the front teeth with a fingertip. This image depicts the administration method for Sitavig, demonstrating the topical application of the medication inside the mouth.*

FDA Label Image

Principal Display Panel (50 mg Tablet Blister Pack Carton)

Packaging label for Sitavig 50 mg buccal tablets by EPI Health, Inc. The label shows the product name, active ingredient acyclovir, and dosage strength of 50 mg. The package contains 2 blisters, each with one 50 mg buccal tablet. Additional information includes storage instructions and distributor contact details.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.